Skip to main content
SpringerLink
Log in
Book cover

Problem Based Learning Discussions in Neuroanesthesia and Neurocritical Care pp 153–162Cite as

Management of Patient with Moyamoya Disease

  • Chapter
  • First Online:

  • 621 Accesses

Abstract

A 45-year-old male patient with moyamoya disease is scheduled for a superficial temporal to middle cerebral artery bypass. He has a past medical history of hypertension and stroke with residual left arm weakness.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226–37.

    Article  CAS  PubMed  Google Scholar 

  2. Parray T, Martin TW, Siddiqui S. Moyamoya disease: a review of the disease and anesthetic management. J Neurosurg Anesthesiol. 2011;23(2):100–9.

    Article  PubMed  Google Scholar 

  3. Baaj AA, et al. Surgical management of moyamoya disease: a review. Neurosurg Focus. 2009;26(4):E7.

    Article  PubMed  Google Scholar 

  4. Kuriyama S, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke. 2008;39(1):42–7.

    Article  PubMed  Google Scholar 

  5. Chiu D, et al. Clinical features of moyamoya disease in the United States. Stroke. 1998;29(7):1347–51.

    Article  CAS  PubMed  Google Scholar 

  6. Choi JU, et al. Natural history of moyamoya disease: comparison of activity of daily living in surgery and non surgery groups. Clin Neurol Neurosurg. 1997;99(Suppl 2):S11–8.

    Article  PubMed  Google Scholar 

  7. Yilmaz EY, et al. Moyamoya: Indiana University Medical Center experience. Arch Neurol. 2001;58(8):1274–8.

    Article  CAS  PubMed  Google Scholar 

  8. Hosain SA, et al. Use of a calcium channel blocker (nicardipine HCl) in the treatment of childhood moyamoya disease. J Child Neurol. 1994;9(4):378–80.

    Article  CAS  PubMed  Google Scholar 

  9. Hallemeier CL, et al. Clinical features and outcome in north American adults with moyamoya phenomenon. Stroke. 2006;37(6):1490–6.

    Article  PubMed  Google Scholar 

  10. Smith ER, Scott RM. Surgical management of moyamoya syndrome. Skull Base. 2005;15(1):15–26.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7(11):1056–66.

    Article  PubMed  Google Scholar 

  12. Guzman R, et al. Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg. 2009;111(5):927–35.

    Article  PubMed  Google Scholar 

  13. Mesiwala AH, et al. Long-term outcome of superficial temporal artery-middle cerebral artery bypass for patients with moyamoya disease in the US. Neurosurg Focus. 2008;24(2):E15.

    Article  PubMed  Google Scholar 

  14. Andrews BT, Chater NL, Weinstein PR. Extracranial-intracranial arterial bypass for middle cerebral artery stenosis and occlusion. Operative results in 65 cases. J Neurosurg. 1985;62(6):831–8.

    Article  CAS  PubMed  Google Scholar 

  15. Sakurai K, et al. A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet. 2004;49(5):278–81.

    Article  CAS  PubMed  Google Scholar 

  16. Trigeminal neuralgia. Surg Neurol. 1996;45(5):406–8.

    Google Scholar 

  17. Fujimura M, et al. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol. 2009;71(4):442–7.

    Article  PubMed  Google Scholar 

  18. Manceau E, Giroud M, Dumas R. Moyamoya disease in children. A review of the clinical and radiological features and current treatment. Childs Nerv Syst. 1997;13(11–12):595–600.

    Article  CAS  PubMed  Google Scholar 

  19. Suzuki J, Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20(3):288–99.

    Article  CAS  PubMed  Google Scholar 

  20. Fukuyama Y, Umezu R. Clinical and cerebral angiographic evolutions of idiopathic progressive occlusive disease of the circle of Willis (“moyamoya” disease) in children. Brain Dev. 1985;7(1):21–37.

    Article  CAS  PubMed  Google Scholar 

  21. Baykan N, et al. Moyamoya disease and anesthesia. Paediatr Anaesth. 2005;15(12):1111–5.

    Article  PubMed  Google Scholar 

  22. Nomura S, et al. Perioperative management protocols for children with moyamoya disease. Childs Nerv Syst. 2001;17(4–5):270–4.

    Article  CAS  PubMed  Google Scholar 

  23. Soriano SG, Sethna NF, Scott RM. Anesthetic management of children with moyamoya syndrome. Anesth Analg. 1993;77(5):1066–70.

    Article  CAS  PubMed  Google Scholar 

  24. Ogawa A, et al. Cerebral blood flow in moyamoya disease. Part 2: autoregulation and CO2 response. Acta Neurochir. 1990;105(3–4):107–11.

    Article  CAS  PubMed  Google Scholar 

  25. Kuwabara Y, et al. Response to hypercapnia in moyamoya disease. Cerebrovascular response to hypercapnia in pediatric and adult patients with moyamoya disease. Stroke. 1997;28(4):701–7.

    Article  CAS  PubMed  Google Scholar 

  26. Kikuta K, et al. Effects of intravenous anesthesia with propofol on regional cortical blood flow and intracranial pressure in surgery for moyamoya disease. Surg Neurol. 2007;68(4):421–4.

    Article  PubMed  Google Scholar 

  27. Astrup J, et al. Minimum cerebral blood flow and metabolism during craniotomy. Effect of thiopental loading. Acta Anaesthesiol Scand. 1984;28(5):478–81.

    Article  CAS  PubMed  Google Scholar 

  28. Cold GE, et al. CBF and CMRO2 during continuous etomidate infusion supplemented with N2O and fentanyl in patients with supratentorial cerebral tumour. A dose-response study. Acta Anaesthesiol Scand. 1985;29(5):490–4.

    Article  CAS  PubMed  Google Scholar 

  29. Kurehara K, et al. Cortical blood flow response to hypercapnia during anaesthesia in Moyamoya disease. Can J Anaesth. 1993;40(8):709–13.

    Article  CAS  PubMed  Google Scholar 

  30. Adachi K, et al. Early postoperative complications in patients with Moyamoya disease—a comparison of inhaled anesthesia with total intravenous anesthesia (TIVA). Masui. 2005;54(6):653–7.

    PubMed  Google Scholar 

  31. Sakamoto T, et al. Risk factors for neurologic deterioration after revascularization surgery in patients with moyamoya disease. Anesth Analg. 1997;85(5):1060–5.

    Article  CAS  PubMed  Google Scholar 

  32. Michenfelder JD. Anesthesia for cerebral surgery. In: Stanley TH, Petty WC, editors. New anesthetic agents, devices and monitoring. 1st ed; 1983. p. 45–9.

    Chapter  Google Scholar 

  33. Brown SC, Lam AM. Moyamoya disease—a review of clinical experience and anaesthetic management. Can J Anaesth. 1987;34(1):71–5.

    Article  CAS  PubMed  Google Scholar 

  34. Kansha M, et al. Anesthetic management of children with moyamoya disease. Clin Neurol Neurosurg. 1997;99(Suppl 2):S110–3.

    Article  PubMed  Google Scholar 

  35. Sato K, Shirane R, Yoshimoto T. Perioperative factors related to the development of ischemic complications in patients with moyamoya disease. Childs Nerv Syst. 1997;13(2):68–72.

    Article  CAS  PubMed  Google Scholar 

  36. Iwama T, Hashimoto N, Yonekawa Y. The relevance of hemodynamic factors to perioperative ischemic complications in childhood moyamoya disease. Neurosurgery. 1996;38(6):1120–5. discussion 1125-6

    CAS  PubMed  Google Scholar 

  37. Orihashi K, et al. Near-infrared spectroscopy for monitoring cerebral ischemia during selective cerebral perfusion. Eur J Cardiothorac Surg. 2004;26(5):907–11.

    Article  PubMed  Google Scholar 

  38. Yusa T, Yamashiro K. Local cortical cerebral blood flow and response to carbon dioxide during anesthesia in patients with moyamoya disease. J Anesth. 1999;13(3):131–5.

    Article  CAS  PubMed  Google Scholar 

  39. Tagawa T, et al. Regional cerebral blood flow, clinical manifestations, and age in children with moyamoya disease. Stroke. 1987;18(5):906–10.

    Article  CAS  PubMed  Google Scholar 

  40. Sumikawa K, Nagai H. Moyamoya disease and anesthesia. Anesthesiology. 1983;58(2):204–5.

    Article  CAS  PubMed  Google Scholar 

  41. Zipfel GJ, Fox DJ Jr, Rivet DJ. Moyamoya disease in adults: the role of cerebral revascularization. Skull Base. 2005;15(1):27–41.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Kim SH, et al. Risk factors for postoperative ischemic complications in patients with moyamoya disease. J Neurosurg. 2005;103(5 Suppl):433–8.

    PubMed  Google Scholar 

  43. Lee SH, et al. Optimum degree of hemodilution for brain protection in a canine model of focal cerebral ischemia. J Neurosurg. 1994;80(3):469–75.

    Article  CAS  PubMed  Google Scholar 

  44. Veeravagu A, et al. Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions. Neurosurg Focus. 2008;24(2):E16.

    Article  PubMed  Google Scholar 

  45. Malley RA, Frost EA. Moyamoya disease: pathophysiology and anesthetic management. J Neurosurg Anesthesiol. 1989;1(2):110–4.

    Article  CAS  PubMed  Google Scholar 

  46. Januszewski J, et al. Flow-based evaluation of cerebral revascularization using near-infrared indocyanine green videoangiography. Neurosurg Focus. 2014;36(2):E14.

    Article  PubMed  Google Scholar 

  47. Pandey P, Steinberg GK. Neurosurgical advances in the treatment of moyamoya disease. Stroke. 2011;42(11):3304–10.

    Article  PubMed  Google Scholar 

  48. Chu W, et al. Anaphylactic shock after intravenous administration of indocyanine green during robotic partial nephrectomy. Urol Case Rep. 2017;12:37–8.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Olsen TW, et al. Anaphylactic shock following indocyanine green angiography. Arch Ophthalmol. 1996;114(1):97.

    Article  CAS  PubMed  Google Scholar 

  50. Kaku Y, et al. STA-MCA bypass under local anesthesia. Acta Neurochir Suppl. 2018;129:79–84.

    Article  PubMed  Google Scholar 

  51. Ngan Kee WD, Gomersall CD. Extradural anaesthesia for caesarean section in a patient with moyamoya disease. Br J Anaesth. 1996;77(4):550–2.

    Article  CAS  PubMed  Google Scholar 

  52. Sharma SK, et al. Epidural anesthesia for a patient with moyamoya disease presenting for cesarean section. Anesth Analg. 1994;79(1):183–5.

    Article  CAS  PubMed  Google Scholar 

  53. Venkatesh B, Taggart PC. Anaesthetic management of a patient with Moyamoya disease for caesarean section. Can J Anaesth. 1994;41(1):79–80.

    Article  CAS  PubMed  Google Scholar 

  54. Abouleish E, Wiggins M, Ali V. Combined spinal and epidural anesthesia for cesarean section in a parturient with moyamoya disease. Acta Anaesthesiol Scand. 1998;42(9):1120–3.

    Article  CAS  PubMed  Google Scholar 

  55. Ahn HJ, et al. Effect of preoperative skull block on pediatric moyamoya disease. J Neurosurg Pediatr. 2008;2(1):37–41.

    Article  PubMed  Google Scholar 

  56. Chui J, et al. Anesthetic management of patients undergoing intracranial bypass procedures. Anesth Analg. 2015;120(1):193–203.

    Article  CAS  PubMed  Google Scholar 

  57. Yu J, et al. Progress on complications of direct bypass for moyamoya disease. Int J Med Sci. 2016;13(8):578–87.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Iwama T, et al. Peri-operative complications in adult moyamoya disease. Acta Neurochir. 1995;132(1–3):26–31.

    Article  CAS  PubMed  Google Scholar 

  59. Fung LW, Thompson D, Ganesan V. Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst. 2005;21(5):358–64.

    Article  PubMed  Google Scholar 

  60. Scott RM, et al. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg. 2004;100(2 Suppl Pediatrics):142–9.

    PubMed  Google Scholar 

  61. Aoki N. Cerebrovascular bypass surgery for the treatment of Moyamoya disease: unsatisfactory outcome in the patients presenting with intracranial hemorrhage. Surg Neurol. 1993;40(5):372–7.

    Article  CAS  PubMed  Google Scholar 

  62. Huang Z, et al. Clinical features and outcomes in 154 patients with haemorrhagic moyamoya disease: comparison of conservative treatment and surgical revascularization. Neurol Res. 2015;37(10):886–92.

    Article  PubMed  Google Scholar 

  63. Park W, et al. Intracranial hemorrhage after superficial temporal artery-middle cerebral artery direct anastomosis for adults with moyamoya disease. World Neurosurg. 2018;119:e774–82.

    Article  PubMed  Google Scholar 

  64. Yoshida Y, et al. Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: an extensive follow-up study. Stroke. 1999;30(11):2272–6.

    Article  CAS  PubMed  Google Scholar 

  65. Fujimura M, et al. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography. Neurosurgery. 2011;68(4):957–64; discussion 964-5.

    Article  PubMed  Google Scholar 

  66. Fujimura M, Tominaga T. Lessons learned from moyamoya disease: outcome of direct/indirect revascularization surgery for 150 affected hemispheres. Neurol Med Chir (Tokyo). 2012;52(5):327–32.

    Article  Google Scholar 

  67. Zhao WG, et al. Cerebral hyperperfusion syndrome after revascularization surgery in patients with moyamoya disease. Br J Neurosurg. 2013;27(3):321–5.

    Article  PubMed  Google Scholar 

  68. Abd-El-Barr MM, et al. Recombinant human bone morphogenetic protein-2 as an adjunct for spine fusion in a pediatric population. Pediatr Neurosurg. 2011;47(4):266–71.

    Article  PubMed  Google Scholar 

  69. Zhao M, et al. Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease. J Neurosurg. 2018;1:1–12.

    CAS  Google Scholar 

  70. Bacigaluppi S, et al. The contribution of imaging in diagnosis, preoperative assessment, and follow-up of moyamoya disease: a review. Neurosurg Focus. 2009;26(4):E3.

    Article  PubMed  Google Scholar 

  71. Fujimura M, et al. Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease. Cerebrovasc Dis. 2012;33(5):436–45.

    Article  PubMed  Google Scholar 

  72. Inoue T, et al. Annual rupture risk of growing unruptured cerebral aneurysms detected by magnetic resonance angiography. J Neurosurg. 2012;117(1):20–5.

    Article  PubMed  Google Scholar 

  73. Sekhar LN, et al. Cerebral revascularization for ischemia, aneurysms, and cranial base tumors. Neurosurgery. 2008;62(6 Suppl 3):1373–408; discussion 1408-10.

    PubMed  Google Scholar 

  74. Jung YJ, et al. Ischemic complications occurring in the contralateral hemisphere after surgical treatment of adults with moyamoya disease. J Korean Neurosurg Soc. 2011;50(6):492–6.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Uchino H, et al. Edaravone reduces hyperperfusion-related neurological deficits in adult moyamoya disease: historical control study. Stroke. 2016;47(7):1930–2.

    Article  CAS  PubMed  Google Scholar 

  76. Fujimura M, et al. Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease. Neurosurgery. 2014;74(2):163–70; discussion 170.

    Article  PubMed  Google Scholar 

  77. Matsushima Y, et al. Perioperative complications of encephalo-duro-arterio-synangiosis: prevention and treatment. Surg Neurol. 1991;36(5):343–53.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Massachusetts Medical School, Worcester, MA, USA

    Elias Nammour

  2. Department of Anesthesiology and Perioperative Medicine, University of Massachusetts Medical School, Worcester, MA, USA

    Eman Nada

Authors
  1. Elias Nammour
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eman Nada
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eman Nada .

Editor information

Editors and Affiliations

  1. Department of Neuroanesthesiology & Critical Care, All India Institute of Medical Sciences, New Delhi, Delhi, India

    Hemanshu Prabhakar

  2. Vice chair for education & Associate Director of Neuroanesthesiology, Allegheny Health Network, Pittsburgh, PA, USA

    Shobana Rajan

  3. Department of Neuroanesthesiology & Critical Care, All India Institute of Medical Sciences, New Delhi, Delhi, India

    Indu Kapoor

  4. Department of Neuroanesthesiology & Critical Care, All India Institute of Medical Sciences, New Delhi, Delhi, India

    Charu Mahajan

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nammour, E., Nada, E. (2020). Management of Patient with Moyamoya Disease. In: Prabhakar, H., Rajan, S., Kapoor, I., Mahajan, C. (eds) Problem Based Learning Discussions in Neuroanesthesia and Neurocritical Care. Springer, Singapore. https://doi.org/10.1007/978-981-15-0458-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-0458-7_13

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-0457-0

  • Online ISBN: 978-981-15-0458-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation